PALO ALTO, CA — Nanosys Inc., the leader in nanotechnology enabled systems, today announced the closing of a $15 million Series B financing. The series was financed by five top-tier venture capital firms. Series A investors — ARCH Venture Partners, CW Group, Polaris Venture Partners, and Venrock Associates — were joined by Prospect Venture Partners for this round. The financing will enable Nanosys to broaden its multi-disciplinary team, further enhance its core technology base, and develop prototype devices in the fields of molecular sensing, optoelectronics, and nanoelectronics.
In addition, Nanosys finalized an agreement with Alexandria Real Estate Equities, who also participated in this round of financing, to lease a state-of-the-art laboratory facility in Palo Alto, California. This laboratory will serve as Nanosys’ corporate headquarters and complement the company’s current laboratory in Boston.
CHANTILLY, — NEC Eluminant Technologies Inc. today announced that it has finalized a funding agreement with Yasuda Enterprise Development Co., Ltd. (YEDC) to support eLUMINANT’s growth in fiber-based, broadband products and services.
Yasuda Enterprise Development Co. Ltd. is one of the largest venture capital companies in Japan. Their investment of $5 million in eLUMINANT, in addition to investments of $26 million announced last fall, brings eLUMINANT’s total Series A funding to $31 million during the past four months.
MENLO PARK, CA — DCM-Doll Capital Management today announced it has added Phillip “Dunk” Dunkelberger to its Entrepreneur-in-Residence (EIR) program.
Dunkelberger was most recently president and CEO of Embark, a DCM portfoliocompany that was acquired by Princeton Review. Prior to Embark, he waspresident and COO of Vantive Corporation before its acquisition by PeopleSoft.Dunkelberger also served as president and CEO of Pretty Good Privacy (PGP), asupplier of e-security software to 3 million customers worldwide, which wasacquired by Network Associates.
HELSINKI, FINLAND — Instrumentarium (Nasdaq: INMRY) announced today that it has entered into an agreement to sell certain assets and operations of Merivaara to a management-led group backed by venture capital company 3i. The operations of Merivaara to be divested include the development, manufacture, marketing and sales of hospital furniture in Finland and Norway. In Norway, sales and support of anesthesia and critical care products and services will be continued by Datex-Ohmeda.
SAN FRANCISCO — Probitas Partners, an integrated, global, alternative investment solutions provider, today named Dale J. Meyer to the position of Partner. Mr. Meyer brings to Probitas fourteen years of experience and will lead Probitas’ efforts from its new office in New York City.
Dale was formerly Managing Director and Group Head of JP Morgan’s Private Fund Group where he initiated, developed and managed a global team dedicated to fundraising for private equity and alternative investment partnerships. While at JP Morgan, Dale and his team raised $8 billion of institutional capital for 15 different buyout, venture capital, hedge, secondary and structured investment products.
TEMPE, AZ — Corrent Corp. Thursday announced that it has raised $16 million in its third
round of funding, led by venture firm United Investments.
Joining them in the new round are world-leading semiconductor foundry United
Microelectronics Corp., Infineon Technologies AG (FSE/NYSE:IFX), a leading
global provider of semiconductor and system solutions, and the company’s
initial investor, Battery Ventures.
Last year, Morgan Stanley led a second round of funding of $7.5M and Battery
Ventures led the company’s initial round in 2000. To date, Corrent has raised
more than $32 million in venture funding.
BOULDER, CO — NaPro BioTherapeutics Inc.(Nasdaq:NPRO) today announced that it has raised a total of $16 million from TL Ventures through the private placement of common stock and convertible debentures. The financing consisted of $8 million of NaPro common stock issued at $9.00 per share and $8 million face value of five-year 4% debentures convertible into common stock at $15 per share. The implied blended price for the transaction is $11.25 per share. No placement agent was involved in the transaction.
ENGLEWOOD, CO — Medical Simulation Corp. (MSC), a simulation technology company, announced today that it is currently oversubscribed in its most recent offering of preferred stock, in which it raised $5 million. In addition, the company has announced that it has elected two new members to its Board of Directors.
TORONTO — NB Capital Partners, the leading independent manager of private equity and debt capital for the Canadian early-stage and mid-markets, announced it has changed its name to EdgeStone Capital Partners. With more than $1 billion under management, EdgeStone has the size, expertise and business network to help promising companies achieve their full potential.
|This is a free sample of content available to paid subscribers of Private Equity Week.
Click here for more information.